TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA CELL BASED ASSAYS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 NORTH AMERICA CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
2.8 DBMR MARKET POSITION GRID
2.9 DBMR VENDOR SHARE ANALYSIS
2.10 MULTIVARIATE MODELING
2.11 PRODUCTS LIFELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING INCIDENCE OF CHRONIC DISEASES
3.1.2 RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
3.1.3 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
3.2 RESTRAINT
3.2.1 STRINGENT REGULATORY REQUIREMENTS
3.2.2 HIGH COST OF INSTRUMENTATION
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENTS
3.3.2 STRATEGIC INITIATIVE BY THE MARKET PLAYERS
3.4 CHALLENGES
3.4.1 CHALLENGING ANALYSIS PROCEDURE
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY TYPE
6.1 OVERVIEW
6.2 CELL VIABILITY ASSAY
6.3 CYTOTOXICITY ASSAY
6.4 CELL PROLIFERATION ASSAY
6.5 CELL DEATH ASSAY
6.6 OTHERS
7 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 ASSAY KITS
7.2.2 CELL LINES
7.2.2.1 PRIMARY CELL LINES
7.2.2.2 STEM CELL LINES
7.2.2.3 IMMORTALIZED CELL LINES
7.2.3 REAGENTS
7.2.4 MICROPLATES
7.3 SERVICES
7.4 INSTRUMENTS AND SOFTWARE
8 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 HIGH THROUGHPUT SCREENING
8.3 FLOW CYTOMETRY
8.4 HIGH CONTENT SCREENING
8.5 LABEL FREE DETECTION
9 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISCOVERY
9.2.1 PREDICTIVE TOXICOLOGY
9.2.2 PHARMACODYNAMIC STUDIES
9.2.3 ADME RESEARCH
9.3 BASIC RESEARCH
9.4 OTHERS
?
10 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTIONS
10.5 GOVERNMENT ORGANIZATIONS
10.6 OTHERS
11 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT
11.3 INDIRECT
12 NORTH AMERICA CELL BASED ASSAY MARKET, BY GEOGRAPHY
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 NORTH AMERICA CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 COMPANY PROFILE
15.1 GENERAL ELECTRIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 DANAHER
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 AGILENT TECHNOLOGIES, INC.
15.3.1.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 THERMO FISHER SCIENTIFIC INC
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 MERCK KGAA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 PERKINELMER INC, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIO-RAD LABORATORIES, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 ATCC
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 AURELIA BIOSCIENCE LTD.
15.9.1 COMPANY SNAPSHOT
15.9.2 SERVICE PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.10 BD
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIOAGILYTIX LABS
15.11.1 COMPANY SNAPSHOT
15.11.2 SERVICE PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 BIOVISION INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CELL SIGNALING TECHNOLOGY, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 CISBIO
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 ENZO BIOCHEM INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 EUROFINS SCIENTIFIC
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT AND SERVICE PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 LAKEPHARMA, INC.
15.17.1 COMPANY SNAPSHOT
15.17.2 SERVICE PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 LONZA
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 SERVICE PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 MILTENYI BIOTEC
15.19.1 COMPANY SNAPSHOT
15.19.2.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.20 XENO DIAGNOSTICS, LLC.
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS